ChampionX Full Year 2023 Earnings: EPS Misses Expectations

In This Article:

ChampionX (NASDAQ:CHX) Full Year 2023 Results

Key Financial Results

  • Revenue: US$3.76b (down 1.3% from FY 2022).

  • Net income: US$314.2m (up 103% from FY 2022).

  • Profit margin: 8.4% (up from 4.1% in FY 2022). The increase in margin was driven by lower expenses.

  • EPS: US$1.60 (up from US$0.77 in FY 2022).

revenue-and-expenses-breakdown
NasdaqGS:CHX Revenue and Expenses Breakdown February 7th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

ChampionX EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.1%.

The primary driver behind last 12 months revenue was the Production Chemical Technologies segment contributing a total revenue of US$2.40b (64% of total revenue). Notably, cost of sales worth US$2.62b amounted to 70% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$633.0m (77% of total expenses). Explore how CHX's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Energy Services industry in the US.

Performance of the American Energy Services industry.

The company's shares are up 5.8% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on ChampionX's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.